Back

Prognosis of refractory shock in de-novo versus worsening Heart Failure: Insight from the HYPO-ECMO trial.

20 May 2023 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - treatment 1 Nonpharmacological Treatment HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Guillaume Baudry

University Hospital of Brabois, Nancy (France)

4 More presentations in this session

Presentation thumbnail
Using urine output trending for the management of acute cardio-renal syndrome in patients with acute decompensated heart failure
Professor Y. Shacham (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Continuous monitoring of advanced hemodynamic parameters during hemodialysis demonstrated early variations in patients experiencing intradialytic hypotension
Doctor D. Nachman (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Cardiogenic shock in acute coronary syndrome and the use of mechanical circulatory support - is there a benefit?
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides
Presentation thumbnail
Individualized recommendations for treating patients with acute kidney injury in the setting of acute heart failure by a novel strategy using causal machine learning
Assistant Professor O. Caspi (Haifa, IL)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure - treatment 1

The Event

Event poster

Heart Failure 2023

20 May 2023 16:00 CET
You may be interested in
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources